Supraglottic Carcinoma Treated with Curative Radiation Therapy: Identification of Prognostic Groups with MR Imaging

PURPOSE: To retrospectively assess the prognostic meaning of tumor characteristics depicted on pretreatment magnetic resonance (MR) images for local outcome in supraglottic squamous cell carcinoma treated with definitive radiation therapy.

MATERIALS AND METHODS: Pretreatment MR images acquired in 84 patients with supraglottic carcinoma treated with curative radiation therapy were reviewed for tumor involvement of laryngeal sites including glottis, subglottis, pre-epiglottic space, laryngeal cartilages, and hypopharynx, and for extralaryngeal extension. The volume of each tumor was estimated, and mean tumor volume was calculated for the group of tumors in each T staging category.

RESULTS: Results of univariate analysis showed MR imaging–determined primary tumor volume (P = .03), involvement of pre-epiglottic space (P = .008), abnormal signal intensity in thyroid cartilage (P = .04), and extralaryngeal extension beyond thyroid and/or cricoid cartilage (P = .02) to be significant predictors of local control rate. Results of multivariate analysis with the Cox regression model confirmed statistical significance for invasion of pre-epiglottic space (P = .004) and for abnormal signal intensities in thyroid cartilage adjacent to the anterior commissure (P = .04) and in cricoid cartilage (P = .01). Five-year local control rates were calculated from the regression coefficients of three independent MR imaging prognostic factors, and three prognostic groups were identified on the basis of these control rates. The 5-year local control rate in the high-risk group was 35%, significantly lower than the rates in the intermediate- and low-risk groups (60% and 89%, respectively; P = .002).

CONCLUSION: MR imaging–determined pre-epiglottic space involvement and abnormal signal intensities in the thyroid cartilage adjacent to the anterior commissure and/or the cricoid cartilage are strong predictors of local outcome in supraglottic carcinoma treated with definitive radiation therapy.

© RSNA, 2004


  • 1 Ali S, Tiwari R, Snow GB, Van der Waal I. Incidence of squamous cell carcinoma of the head and neck: report of 1,000 cases. J Laryngol Otol 1986; 100:315-327. Crossref, MedlineGoogle Scholar
  • 2 Million RR. The larynx … so to speak: everything I wanted to know about laryngeal cancer I learned in the last 32 years. Int J Radiat Oncol Biol Phys 1992; 23:691-704. Crossref, MedlineGoogle Scholar
  • 3 Bailey BJ. Beyond the ‘new’ TNM classification (editorial). Arch Otolaryngol Head Neck Surg 1991; 117:369-370. Crossref, MedlineGoogle Scholar
  • 4 Piccirillo JF. Purposes, problems, and proposals for progress in cancer staging. Arch Otolaryngol Head Neck Surg 1995; 121:145-149. Crossref, MedlineGoogle Scholar
  • 5 Isaacs JH, Mancuso AA, Mendenhall WM, Parsons JT. Deep spread patterns in CT staging of T2–4 squamous cell laryngeal carcinoma. Otolaryngol Head Neck Surg 1988; 99:455-464. Crossref, MedlineGoogle Scholar
  • 6 Hermans R, Van den Bogaert W, Rijnders A, Baert AL. Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys 1999; 44:755-765. Crossref, MedlineGoogle Scholar
  • 7 Pameijer FA, Balm AJ, Hilgers FJ, Muller SH. Variability of tumor volumes in T3-staged head and neck tumors. Head Neck 1997; 19:6-13. Crossref, MedlineGoogle Scholar
  • 8 Mukherji SK, O’Brien SM, Gerstle RJ, et al. The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx. Head Neck 2000; 22:282-287. Crossref, MedlineGoogle Scholar
  • 9 Gilbert RW, Birt D, Shulman H, et al. Correlation of tumor volume with local control in laryngeal carcinoma treated by radiotherapy. Ann Otol Rhinol Laryngol 1987; 96:514-518. Crossref, MedlineGoogle Scholar
  • 10 Freeman DE, Mancuso AA, Parsons JT, Mendenhall WM, Million RR. Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? Int J Radiat Oncol Biol Phys 1990; 19:485-490. Crossref, MedlineGoogle Scholar
  • 11 Mancuso AA, Mukherji SK, Schmalfuss I, et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999; 17:631-637. Crossref, MedlineGoogle Scholar
  • 12 Hermans R, Feron M, Bellon E, Dupont P, Van den Bogaert W, Baert AL. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys 1998; 40:553-557. Crossref, MedlineGoogle Scholar
  • 13 Kraas JR, Underhill TE, D’Agostino RB, Jr, Williams DW, Cox JA, Greven KM. Quantitative analysis from CT is prognostic for local control of supraglottic carcinoma. Head Neck 2001; 23:1031-1036. Crossref, MedlineGoogle Scholar
  • 14 Maroldi R, Battaglia G, Maculotti P, Cabassa P, Chiesa A. Computed tomography scanning of supraglottic neoplasms: its cost-effective use in preoperative staging. Acad Radiol 1996; 3(suppl 1):S57-S59. Crossref, MedlineGoogle Scholar
  • 15 Castelijns JA, Gerritsen GJ, Kaiser MC, et al. Invasion of laryngeal cartilage by cancer: comparison of CT and MR imaging. Radiology 1988; 167:199-206. LinkGoogle Scholar
  • 16 Becker M, Zbaren P, Laeng H, Stoupis C, Porcellini B, Vock P. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology 1995; 194:661-669. LinkGoogle Scholar
  • 17 Castelijns JA, Van den Brekel MW, Smit EM, et al. Predictive value of MR imaging-dependent and non-MR imaging-dependent parameters for recurrence of laryngeal cancer after radiation therapy. Radiology 1995; 196:735-739. LinkGoogle Scholar
  • 18 Castelijns JA, Van den Brekel MW, Tobi H, et al. Laryngeal carcinoma after radiation therapy: correlation of abnormal MR imaging signal patterns in laryngeal cartilage with the risk of recurrence. Radiology 1996; 198:151-155. LinkGoogle Scholar
  • 19 Castelijns JA, Golding RP, Van Schaik C, Valk J, Snow GB. MR findings of cartilage invasion by laryngeal cancer: value in predicting outcome of radiation therapy. Radiology 1990; 174:669-673. LinkGoogle Scholar
  • 20 Castelijns JA, Becker M, Hermans R. Impact of cartilage invasion on treatment and prognosis of laryngeal cancer. Eur Radiol 1996; 6:156-169. Crossref, MedlineGoogle Scholar
  • 21 Sobin LH, Wittekind C. TNM classification of malignant tumors International Union Against Cancer. 6th ed. New York, NY: Wiley-Liss, 2002; 36-42. Google Scholar
  • 22 Castelijns JA, Kaiser MC, Valk J, Gerritsen GJ, Van Hattum AH, Snow GB. MR imaging of laryngeal cancer. J Comput Assist Tomogr 1987; 11:134-140. Crossref, MedlineGoogle Scholar
  • 23 Castelijns JA, Gerritsen GJ, Kaiser MC, et al. MRI of normal or cancerous laryngeal cartilages: histopathologic correlation. Laryngoscope 1987; 97:1085-1093. Crossref, MedlineGoogle Scholar
  • 24 Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Mancuso AA. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003; 25:535-542. Crossref, MedlineGoogle Scholar
  • 25 Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49:6449-6465. MedlineGoogle Scholar
  • 26 Giron J, Joffre P, Serres-Cousine O, Bonafe A, Senac JP. Pre-therapeutic evaluation of laryngeal carcinomas using computed tomography and magnetic resonance imaging. Isr J Med Sci 1992; 28:225-232. MedlineGoogle Scholar
  • 27 Fletcher GH, Hamberger AD. Causes of failure in irradiation of squamous-cell carcinoma of the supraglottic larynx. Radiology 1974; 111:697-700. LinkGoogle Scholar
  • 28 Dursun G, Keser R, Aktürk T, Akìner MN, Demireller A, Sak SD. The significance of pre-epiglottic space invasion in supraglottic laryngeal carcinomas. Eur Arch Otorhinolaryngol 1997; 254(suppl 1):S110-S112. Crossref, MedlineGoogle Scholar
  • 29 Giron J, Joffre P, Serres-Cousine O, Senac JP. CT and MR evaluation of laryngeal carcinomas. J Otolaryngol 1993; 22:284-293. MedlineGoogle Scholar
  • 30 Katsounakis J, Remy H, Vuong T, Gélinas M, Tabah R. Impact of magnetic resonance imaging and computed tomography on the staging of laryngeal cancer. Eur Arch Otorhinolaryngol 1995; 252:206-208. MedlineGoogle Scholar
  • 31 Maheshwar AA, Gaffney CC. Radiotherapy for T1 glottic carcinoma: impact of anterior commissure involvement. J Laryngol Otol 2001; 115:298-301. Crossref, MedlineGoogle Scholar

Article History

Published in print: Aug 2004